Home » Black executive Kenneth Frazier loses $3.7 million from Merck & Co. stake

Black executive Kenneth Frazier loses $3.7 million from Merck & Co. stake

by Mfonobong Nsehe
Kenneth Frazier

Key Points

  • Pioneering Black CEO Kenneth Frazier sees a $3.7 million decline in his Merck holdings due to a recent stock price drop.
  • The pharmaceutical giant’s stock fell 4% on the NYSE, pushing its market cap below $320 billion.
  • Despite the short-term loss for Frazier, Merck remains a strong year-to-date performer, up over 15% for investors.

Kenneth Frazier, the pioneering Black executive who formerly helmed Merck & Co. as its CEO and executive chairman, has experienced a notable setback in his financial stake in the pharmaceutical giant. The market value of his holdings has declined by millions of dollars, reflecting a broader dip in Merck’s share price.

According to data from Billionaires.Africa, Frazier’s equity in Merck & Co. saw a $3.70 million decrease over the past week. This follows a recent period of growth where his stake increased by $4 million between April 18 and May 17, ascending from $88.31 million to $92.3 million.

Merck & Co., a leading entity in the pharmaceutical sector, continues to offer an extensive range of prescription medications, vaccines, biological therapies, and animal health products. The company operates through three main segments: Pharmaceutical, Animal Health, and Other.

Frazier’s Merck stake falls as stock price drops

In recent times, the share price of Merck has suffered a significant pullback. On the New York Stock Exchange (NYSE), the stock has fallen by 4 percent since May 22, dropping from $131.1 to $125.85. This has pushed Merck’s market capitalization below $320 billion, impacting shareholders significantly.

Frazier, a top figure among America’s top Black executives, owns a 0.028-percent stake in Merck & Co., equivalent to 705,220 shares. The valuation of his stake stands at over $88 million, down from $92.45 million on May 22, marking a $3.70 million decline over the past week.

The recent drop in Merck’s shares has caused the market value of Frazier’s stake to decline by $3.7 million over the past seven days, falling from $92.45 million on May 22 to $88.75 million at the time of this report. Despite this decline, Frazier remains a top Black executive.

Your Money and Your Life 

Despite the recent dip in stock value, Kenneth Frazier’s legacy as a trailblazing executive remains intact. His tenure at Merck & Co. is marked by significant advancements and achievements, solidifying his position as a key figure in corporate America.

Merck & Co. has delivered substantial returns to investors this year. The company’s shares have surged by 15.44 percent year-to-date in 2024. A $100,000 investment in Merck at the start of the year would now be valued at $115,440, reflecting a gain of $15,440.

You may also like


The world’s premier source of news on Africa’s billionaires and UHNWIs.


Get the daily email to stay informed about African billionaires and UHNWIs. Get informed and entertained, for free.

Latest News

@2024 – Billionaires.Africa. All Rights Reserved.